Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors
- PMID: 26155039
- PMCID: PMC4491642
- DOI: 10.1016/j.jceh.2015.04.002
Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors
Abstract
Background: Liver steatosis is the leading cause of donor rejection in living donor liver transplantation. Rapid weight loss is difficult to achieve in a short period of time, moreover it has been thought to worsen liver histology.
Methods: Donors who had significant steatosis based on liver biopsy were recommended 1200 Kcal/day and a minimum of 60 min/day moderate cardio training. Two patients were advised statins for dyslipidemia. None of the donors had metabolic syndrome. A second ultrasound guided liver biopsy was done at 28 ± 10 days. Donors with nonalcoholic steatohepatitis/fibrosis or >30% steatosis were not included.
Results: From July 2010 to January 2015, 16 donors were advised aggressive life style modification after initial biopsy; 15 (10 males, age 27.5 ± 6.5 years, baseline body mass index 28.4 ± 2.1 Kg/M(2)) successfully reduced weight and 14 underwent donation after favorable second biopsy. Mean weight loss was 7 ± 4.3 kg (8.4 ± 4.6%). Second liver biopsy was done at 28 ± 10 days, there was decrease in steatosis in all but one including normalization of liver biopsy in 7 donors. Three donors had mild inflammation on first biopsy and they had improvement in second biopsy. All the donors and their recipients had an uneventful post-operative course.
Conclusion: Steatosis can be reversed in a short duration by aggressive life style modifications in highly motivated liver donors.
Keywords: ALT, alanine transaminase; ALT, aspartate transaminase; BMI, body mass index; LAI, liver attenuation index; LDLT, living donor liver transplantation; NAFLD, non-alcoholic fatty liver disease; diet; donor; exercise; life style modification; liver biopsy.
Figures
References
-
- Chalasani N., Younossi Z., Lavine J.E. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005–2023. - PubMed
-
- Furuya C.K., Jr., de Oliveira C.P., de Mello E.S. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol. 2007;22:510–514. - PubMed
-
- Kotecha HL, Saraf N, Saigal S et al. NAFLD is the leading cause of donor rejection in living donor liver transplantation. J Clin Exp Hepatol 3:S3. http://dx.doi.org/10.1016/j.jceh.2013.03. - DOI
-
- Rafiq N., Younossi Z.M. Effects of weight loss on nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28:427–433. - PubMed
-
- Limanond P., Raman S.S., Lassman C. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology. 2004;230:276–280. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
